MHC class I and integrin ligation induce ERK activation via an mTORC2-dependent pathway |
| |
Authors: | Jindra Peter T Jin Yi-Ping Jacamo Rodrigo Rozengurt Enrique Reed Elaine F |
| |
Affiliation: | a UCLA Immunogenetics Center, David Geffen School of Medicine UCLA, 1000 Veteran Avenue Los Angeles, CA 90095, USA b Department of Pathology and Laboratory Medicine, David Geffen School of Medicine UCLA, 1000 Veteran Avenue Los Angeles, CA 90095, USA c Division of Digestive Diseases, Department of Medicine and Molecular Biology Institute, University of California, Los Angeles, CA 90095, USA |
| |
Abstract: | The aim of this study was to characterize the interaction between mTOR and ERK in primary endothelial cells (EC) following MHC class I and integrin ligation. Ligation of MHC class I molecules or integrins on the surface of EC leads to phosphorylation of ERK at Thr202/Tyr204. We utilized small interfering RNA (siRNA) blockade of mTOR and proteins involved in mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) to define a relationship between mTOR and ERK following MHC class I signaling. We found mTORC2 was responsible for MHC class I and integrin induced phosphorylation of ERK at Thr202/Tyr204. We corroborated these results demonstrating that long-term exposure to rapamycin also inhibited ERK pathway activation in response to MHC class I signaling. Our results demonstrate, for the first time, that engagement of either MHC class I or integrin on the surface of EC leads to ERK activation through an mTORC2-dependent pathway. |
| |
Keywords: | MHC HLA class I ERK mTORC2 siRNA Endothelial cells Signal transduction |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|